Recombinant Human PRKRA Protein, N-His

Description of Recombinant Human PRKRA Protein, N-His

Recombinant Human PRKRA Protein: Structure, Activity, and Application

Introduction

Recombinant proteins, also known as r-proteins, are proteins that are produced through genetic engineering techniques. They are created by inserting the gene encoding a specific protein into an expression system, such as bacteria or yeast, and then allowing the organism to produce the protein in large quantities. One such recombinant protein is the human PRKRA protein, which plays a crucial role in various cellular processes. In this article, we will discuss the structure, activity, and application of recombinant human PRKRA protein.

Structure of Recombinant Human PRKRA Protein

The PRKRA protein, also known as protein kinase, interferon-inducible double-stranded RNA-dependent activator, is a 51 kDa protein consisting of 451 amino acids. It is composed of three domains: the N-terminal domain, the central domain, and the C-terminal domain. The N-terminal domain is responsible for interacting with other proteins, while the central domain contains the double-stranded RNA-binding motif. The C-terminal domain is responsible for the activation of protein kinase R (PKR), which is the main function of PRKRA protein.

Activity of Recombinant Human PRKRA Protein

The main activity of PRKRA protein is its role in the activation of PKR, a serine/threonine protein kinase. PKR is activated in response to viral infection or cellular stress and is involved in the regulation of translation and cell survival. PRKRA protein binds to the N-terminal region of PKR, leading to its activation and subsequent phosphorylation of eukaryotic initiation factor 2 alpha (eIF2α). This results in the inhibition of protein synthesis and the induction of cellular defense mechanisms against viral infection.

In addition to its role in PKR activation, PRKRA protein also plays a role in the regulation of microRNA (miRNA) biogenesis. It interacts with the protein Argonaute 2 (AGO2), which is involved in the processing of miRNA precursors. This interaction enhances the activity of AGO2 and promotes the production of mature miRNAs, which are essential for gene regulation and cellular homeostasis.

Application of Recombinant Human PRKRA Protein

The recombinant human PRKRA protein has various applications in both research and therapeutic settings. Its role in the activation of PKR makes it a valuable tool for studying the cellular response to viral infection and cellular stress. It can also be used to investigate the role of PKR in various diseases, such as cancer and neurodegenerative disorders.

In therapeutic applications, recombinant PRKRA protein has shown potential as an antiviral agent. By activating PKR, it can inhibit viral replication and prevent the spread of infection. It has also been studied as a potential treatment for cancer, as PKR activation can induce cell death in cancer cells. Furthermore, the role of PRKRA protein in miRNA biogenesis makes it a potential target for the development of novel therapies for diseases involving dysregulated miRNA expression.

Conclusion

In summary, recombinant human PRKRA protein is a 51 kDa protein with three distinct domains that plays a crucial role in the activation of PKR and regulation of miRNA biogenesis. Its structure and activity make it a valuable tool for studying cellular processes and a potential therapeutic agent for various diseases. Further research on this protein may uncover even more applications and potential uses in the future.